3,4,5-trimethoxy-N-(4-methoxyphenyl)benzamide | 742-15-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3,4,5-trimethoxy-N-(4-methoxyphenyl)benzamide
• 英文别名: 3,4,5-trimethoxy-benzoic acid p-anisidide；3,4,5-Trimethoxy-benzoesaeure-p-anisidid；Trimethylaethergallussaeure-p-anisidid；(4-Methoxy-phenyl)-(3,4,5-trimethoxy-benzoyl)-amin
• CAS: 742-15-4
• 化学式: C₁₇H₁₉NO₅
• mdl: MFCD00558751
• 分子量: 317.342
• InChiKey: BQYHECHXLBBJKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3,4,5-trimethoxy-N-(4-methoxyphenyl)benzamide 在 五氯化磷 作用下， 生成 3,4,5-trimethoxy-N-(4-methoxy-phenyl)-benzimidoyl chloride
  参考文献：
  名称：

  Sonn; Meyer, Chemische Berichte, 1925, vol. 58, p. 1102

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4,5-三甲氧基苯甲酰氯 、 甲氧苯胺 在 三乙胺 作用下， 以 氯仿 为溶剂， 生成 3,4,5-trimethoxy-N-(4-methoxyphenyl)benzamide
  参考文献：
  名称：

  高效三唑基微管蛋白聚合抑制剂。

  摘要：

  我们描述了一系列的微管蛋白聚合抑制剂的合成和生物学评估，这些抑制剂包含1,2,4-三唑环以保留康维他汀A-4（CA-4）中的顺式双键提供的生物活性构型。几种主题化合物显示出对微管蛋白聚合的有效抑制活性以及对多种癌细胞的细胞毒性，包括多重耐药性（MDR）癌细胞系。N-甲基-5-吲哚基部分与1,2,4-三唑核的连接，如化合物7所示，在该系列化合物中具有最佳性能。微管蛋白秋水仙碱结合位点内部的7个计算机对接和分子模拟使得能够鉴定最有可能与这些抑制剂强烈相互作用的残基，并解释了其有效的抗微管蛋白活性和细胞毒性。

  DOI：

  10.1021/jm061142s

文献信息

• The Behavior of 2-Substituted-3-hydroxyisoindolinones in the Reaction with<i>sec</i>-Butyllithium
  作者：A. Jóźwiak、M. Ciechańska

  DOI：10.1002/jhet.1636

  日期：2014.3

  This paper presents a dualistic behavior of 2‐substituted‐3‐hydroxyisoindolones in reactions with sec‐butyllithium (sec‐BuLi). 2‐tert‐Butyl‐3‐hydroxy‐2,3‐dihydro‐1H‐isoindol‐1‐one (1a) treated with sec‐BuLi undergoes metalation at position 7. On the other hand, the reaction between 3‐hydroxy‐2‐phenyl‐2,3‐dihydroxyisoindol‐1‐one (1j) and sec‐BuLi results in 3‐sec‐butyl‐2‐phenyl‐2,3‐dihydroisiondol‐1‐one

  本文介绍了2-取代-3-羟基异吲哚酮与仲丁基锂（sec - BuLi ）的对偶行为。用sec- BuLi处理的2-叔丁基-3-羟基-2,3-二氢-1 H-异吲哚-1-酮（1a）在位置7发生金属化。另一方面，3-羟基-羟基之间的反应2-苯基-2-3,3-二羟基异吲哚-1-酮（1j）和sec- BuLi生成3- sec-丁基-2-苯基-2-3,2-二氢碘吲哚-1-酮（3j）。
• Stable and Reusable Binaphthyl‐Supported Palladium Catalyst for Aminocarbonylation of Aryl Iodides
  作者：Nidhi Sharma、Govindasamy Sekar

  DOI：10.1002/adsc.201500642

  日期：2016.1.21

  A binaphthyl‐supported Pd nanoparticles (Pd‐BNP)‐catalyzed aminocarbonylation of aryl iodides in the presence of carbon monoxide and amines for the synthesis of amides has been developed. This methodology provides an efficient route for the synthesis of a COX‐2 enzyme inhibitor having anti‐inflammatory activity.

  已经开发了在二氧化碳和胺存在下，联萘负载的Pd纳米颗粒（Pd-BNP）催化的芳基碘的氨基羰基化反应，用于合成酰胺。这种方法为合成具有抗炎活性的COX-2酶抑制剂提供了一条有效途径。
• Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization
  作者：Mark Cushman、Dhanapalan Nagarathnam、D. Gopal、Asit K. Chakraborti、Chii M. Lin、Ernest Hamel

  DOI：10.1021/jm00112a036

  日期：1991.8

  An array of cis-, trans-, and dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in the five cancer cell cultures A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma. Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines and these were also found to be active as inhibitors of tubulin polymerization. The most active compounds also inhibited the binding of colchicine to tubulin. The most potent of the new compounds, both as a tubulin polymerization inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (5a). This substance was almost as potent as combretastatin A-4 (1a), the most active of the combretastatins, as a tubulin polymerization inhibitor. Compound 5a was found to be approximately 140 times more cytotoxic against HT-29 colon adenocarcinoma cells and about 10 times more cytotoxic against MCF-7 breast carcinoma cells than combretastatin A-4. However, 5a was found to be about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against MLM melanoma cells than combretastatin A-4. The relative potencies 5a > 8a > 6a for the cis, dihydro, and trans compounds, respectively, as inhibitors of tubulin polymerization are in agreement with the relative potencies previously observed for combretastatin A-4 (1a), dihydrocombretastatin A-4 (1c), and trans-combretastatin A-4 (1b). The relative potencies 5a > 8a > 6a were also reflected in the results of the cytotoxicity assays. Structure-activity relationships of this group of compounds are also discussed.
• Kar, Pharmazie, 1983, vol. 38, # 5, p. 313 - 315
  作者：Kar

  DOI：——

  日期：——
• Discovery of 4-Amino and 4-Hydroxy-1-aroylindoles as Potent Tubulin Polymerization Inhibitors
  作者：Jing-Ping Liou、Zi-Yi Wu、Ching-Chuan Kuo、Chi-Yen Chang、Pei-Yi Lu、Chi-Ming Chen、Hsing-Pang Hsieh、Jang-Yang Chang

  DOI：10.1021/jm800150d

  日期：2008.7.1

  1-Aroylindoline, 1-aroyl-1,2,3,4-tetrahydroquinoline, and 1-aroylindole derivatives were synthesized and evaluated for anticancer activity. The 4-amino and 4-hydroxy-1-aroylindoles 26 and 27 with IC(50) Of 0.9 and 0.6 mu M, respectively, exhibited antitubulin activity superior or comparable to that of colchicine and combretastatin A-4. They also showed antiproliferative activity with IC(50) of 0.3-5.4 nM in a set of human cancer cell lines.